Share

December 2013; 3 (6) Cases

B lymphoblastic leukemia/lymphoma presenting as seventh cranial nerve palsy

Carlos Kamiya-Matsuoka, Pedro Garciarena, Hesham M. Amin, Ivo W. Tremont-Lukats, John F. de Groot
First published August 21, 2013, DOI: https://doi.org/10.1212/CPJ.0b013e3182a78ef0
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
78

Share

Article Information

vol. 3 no. 6 532-534
DOI: 
https://doi.org/10.1212/CPJ.0b013e3182a78ef0
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • First Published August 21, 2013.

Article Versions

Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Carlos Kamiya-Matsuoka, MD,
    2. Pedro Garciarena, MD,
    3. Hesham M. Amin, MD,
    4. Ivo W. Tremont-Lukats, MD and
    5. John F. de Groot, MD
  1. Carlos Kamiya-Matsuoka, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Pedro Garciarena, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Hesham M. Amin, MD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Journal of Cellular and Molcular Medicine, Assistant Editor, 6 years

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Ivo W. Tremont-Lukats, MD and
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. (1)Clinical Case Reports,Associate Editor, since March 2013.

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. John F. de Groot, MD
    6. Scientific Advisory Boards:

    1. 1. Genentech (Advisory Board), 2. VBL Therapeutics (DSMB), 3. Deciphera Therapeutics (Advisory Board)

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Merck, travel and speaker honoraria

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. 1. AstraZeneca, 2. Sanofi-Aventis, 3. Adnexus, 4. EMD- Serono

    Research Support, Government Entities:

    1. NCI, PI, 20102012

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. ASCO Career Development Award

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Departments of Neuro-oncology (CK-M, PG, IWT-L, JFdG) and Hematopathology (HMA), The University of Texas MD Anderson Cancer Center, Houston; and the Department of Neurology (CK-M), The University of Texas Medical Branch, Galveston.
  1. Correspondence to:
    ckmatsuo{at}utmb.edu
View Full Text

Article usage

Article usage: August 2013 to June 2022

AbstractFullPdfSource
Aug 20131001Highwire
Sep 20132501Highwire
Oct 20134204Highwire
Nov 20131013Highwire
Dec 20131181919Highwire
Jan 20149434Highwire
Feb 20146664Highwire
Mar 20144312Highwire
Apr 20143532Highwire
May 20142200Highwire
Jun 2014900Highwire
Jul 2014613Highwire
Aug 20141200Highwire
Sep 20142501Highwire
Oct 20143401Highwire
Nov 2014601Highwire
Dec 2014300Highwire
Jan 2015403Highwire
Feb 2015111Highwire
Mar 20151801Highwire
Apr 2015601Highwire
May 2015602Highwire
Jun 2015500Highwire
Jul 2015810Highwire
Aug 20151110Highwire
Sep 2015502Highwire
Oct 2015700Highwire
Nov 2015201Highwire
Dec 20151500Highwire
Jan 20162000Highwire
Feb 2016400Highwire
Mar 20161201Highwire
Apr 2016100Highwire
May 2016300Highwire
Jun 2016700Highwire
Jul 2016800Highwire
Aug 20162100Highwire
Sep 2016700Highwire
Oct 20161200Highwire
Nov 20161500Highwire
Dec 2016700Highwire
Jan 20171400Highwire
Feb 2017800Highwire
Mar 20171000Highwire
Apr 20171000Highwire
May 20171000Highwire
Jun 2017400Highwire
Jul 2017500Highwire
Aug 2017500Highwire
Sep 2017400Highwire
Oct 2017300Highwire
Nov 2017600Highwire
Dec 20171600Highwire
Jan 20181701Highwire
Feb 20181310Highwire
Mar 20183002Highwire
Apr 20182700Highwire
May 20183024Highwire
Jun 20185900Highwire
Jul 20183001Highwire
Aug 20182601Highwire
Aug 2018342pmc
Sep 20181622Highwire
Oct 20181410Highwire
Nov 20182901Highwire
Dec 20182001Highwire
Jan 20191600Highwire
Feb 2019800Highwire
Mar 20191800Highwire
Apr 20191301Highwire
May 20192000Highwire
Jun 2019600Highwire
Jul 2019700Highwire
Aug 2019600Highwire
Sep 20191610Highwire
Oct 2019700Highwire
Nov 20191011Highwire
Dec 2019500Highwire
Jan 2020800Highwire
Feb 20201200Highwire
Mar 2020600Highwire
Apr 2020300Highwire
May 2020510Highwire
Jun 2020400Highwire
Jul 2020400Highwire
Aug 2020900Highwire
Sep 2020810Highwire
Oct 2020400Highwire
Nov 20201000Highwire
Dec 2020600Highwire
Jan 2021600Highwire
Feb 2021400Highwire
Mar 2021600Highwire
Apr 2021400Highwire
May 20211700Highwire
Jun 2021600Highwire
Jul 20211200Highwire
Aug 20211400Highwire
Sep 2021800Highwire
Oct 2021700Highwire
Nov 2021900Highwire
Dec 20211800Highwire
Jan 2022800Highwire
Feb 20221200Highwire
Mar 2022300Highwire
Apr 20221303Highwire
May 2022700Highwire
Jun 2022400Highwire

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me